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arthritic patient. In both experiments the difference between the means is significant by Student's t test ( P < 0.005), suggesting a decreased reactivity of lymphocytes from rheumatoid-arthritic patients t o phytohaemagglutinin compared with healthy controls.
Preliminary experiments with control lymphocytes stimulated with protein A indicated that the optimum concentration of this mitogen was 10,ug/rnl. The results shown in Table   1 suggest that the optimum incubation period is 4 or 5 days. Table 2 shows the response of lymphocytes from controls and rheumatoid-arthritic patients to various concentrations of protein A when cultured for 4 days. The results of two trials are shown and a different control/patient pair was used ineachcase. As shown in Table 2 , optimal stimulation occurs at a protein A concentrationof IOpg/ml withcellsfromcontrolsandrheumatoid-arthritic patients. With concentrations of 80pglrnl or more the stimulation is only slight and probably not significant. However, over the range 5-5Opg of protein A/ml the stimulation of lymphocytes from rheumatoid-arthritic patients is decreased compared with control cells. At the optimum concentration (10pg/ml), the difference between the means is significant in both trials (P < 0.01).
The decreased mitogenic response of lymphocytes from rheumatoid-arthritic patients t o phytohaernagglutinin suggests a possible defect in T-lymphocyte function, as has been previously suggested by other workers (Horwitz & Garrett, 1977 We have reported previously that the anti-tumour antibiotic adriamycin inhibits the activity of native cardiac (Na+ + K+)-ATPase* at the incredibly low concentration of , 1975) . This inhibition is related to the chelating abilities of adriamycin, because the inhibition of the (Na+ + K+)-ATPase and ion transport is counteracted by Caz+ (van Rossum & Gosalvez, 1976 ) and a metallic derivative of adriamycin made by chelation with ferric iron was not active in the ATPase (Gosalvez, 1976) .
We now report that adriamycin and two other potent chelating agents for ferric iron, compound ICRF-159 and tetrodotoxin, inhibit the capping of surface immunoglobulins at femtomolar ( 1 0 -' 5~) concentrations, Compound ICRF-159 is a derivative of EDTA with strong anti-tumour activity (Hellman et al., 1969) and tetrodotoxin is an inhibitor of Na+ conductance in nerve (Hille, 1968) . The effect of these compounds in capping, a process well known t o depend on cell membrane microfilaments (Schreiner et al., 1977) Adriamycin and tetrodotoxin inhibit 50% of capping at 10-15h.1 and compound ICRF-159 inhibits 25% at 1 O -l '~.
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permits us to speculate that its effect on the (Na+ + K+)-ATPase and ion transport could be mediated through a system of microfilaments. The capping of surface immunoglobulins was measured by fluorescence microscopy by using lymphocytes from the spleen of Swiss mice. Samples of 1 x lo6 lymphocytes suspended in 5 0~1 of phosphate-buffered saline were mixed with 5 0~1 of fluoresceintreated goat antiserum to mouse 7 s y-globulin (2.2mg/ml antibody concentration, Hyland) and lop1 of phosphate-buffered saline containing the amount of drug desired. The mixture was incubated without agitation at 0°C for 4Omin, and then the cells were washed three times with phosphate-buffered saline. The cells were resuspended from the last centrifugation in 0.1 ml of medium 199 (Difco) and were then incubated for 45min at 37°C without agitation to perform the capping. At the end of the warm incubation period, the tubes with the cells were immersed in ice and samples were obtained for observation under fluorescence microscopy. Two observers counted the cells in several fields noting the total number of cells per field, the total number of stained fluorescent cells per field and the number of cells in which the fluorescence was mainly distributed in a cap at one pole of the cells. Capping was expressed as the percentage of cells with caps within the total of stained cells; the average of the values of the two investigators was used.
In our experiments, cell capping in 45min varied between 60 and 80%. Two duplicate tubes were made for each concentration of drug tested. Controls were tubes in which the drug was omitted from the cold incubation. When the drug was diluted to 1 0 -2 2~, which is when there was no drug in the tubes, the capping was 100% of the control; however, at concentrations of 1 0 -2 0~ and above, there is a progressive inhibition of capping with the three drugs along a wide range of concentrations. At 1 0 -1 5~, the inhibition of capping by adriamycin and tetrotoxin is about SO%, and by compound ICRF-159, is about 25 %. To obtain inhibition at such incredibly low concentrations, it is crucial to make the warm incubation (to perform the capping), without agitation, at 37°C and with a duration of at least 46min. It is sufficient to lower the temperature to 30°C to decrease the duration of incubation to 30min or to incubate with agitation to make the inhibition of capping at femtomolar concentrations dis- appear. This fact, and the fact that the inhibition of capping detected at ~O -' O M corresponds to the action of just one molecule of the drug, suggest that the inhibition could be propagated within a cell and from cell to cell by cell contact. Fig. 2 shows the inhibition of capping in a controI cell preparation in which, after washing the fluorescence and during the warm incubation, the cells were mixed with small amounts of three-times-washed cells that had been incubated in the cold with 0.1pM-adriamycin. There was progressive inhibition of capping with increasing concentrations of adriamycin-treated cells. No capping inhibition (100% capping) was obtained when a homogenate of treated cells was added instead of the whole cells, which rules out contamination with residual adriamycin. N o capping inhibition (100% capping) was obtained when ihe warm incubation was carried out with agitation, indicating that it is the permanent contact between inhibited cells with the rest of the cells that causes the inhibition. The experiment in Fig. 2 could indicate that adriamycin induces a change in its receptor and that this change can be propagated within the cell and from cell t o cell on cell contact causing capping inhibition. As capping is a phenomenon well known to depend on membrane microfilaments (Schreiner et al., 1977) , and as the inhibition of capping at ferntomolar concentrationsof adriamycin depends to a great extent on permanent cell contact and temperature, it is tempting to assume that the inhibition caused by a single molecule of drug is propagated by membrane microfilaments within each cell and from cell to cell.
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